Gastric cancer is one of the most common malignant tumor worldwide and has high morbidity and mortality. microRNAs are small, non-coding RNAs which play critical roles in the post-transcriptional regulation of gene expression. In this current study, we used qRT-PCR to detect miR-215 and FOXO1 expression level in 50 paired gastric cancer tissues and found that miR-215 was frequently overexpressed and FOXO1 was down-regulated in GC cancer tissues. Clinicopathological analysis showed that miR-215 expression level was correlated with the progression of tumor invasion and TNM stage. Additionally, transwell invasion assay showed that miR-215 promoted the migration and invasion of gastric cancer cells. We found that miR-215 decreased FOXO1 expression by directly binding to the 3'-untranslated region (UTR) of FOXO1. These results suggest that miR-215 promotes cell migration and invasion of gastric cancer by targeting FOXO1. Therefore, this study provides a promising therapeutic strategy for treating gastric cancer.
Gastric cancer (GC) is one of the most common malignant tumor worldwide and the second leading cause of cancer-related deaths [1] . GC has the highest incidence rate in Eastern Asia, especially in China [1, 2] . Usually, it is difficult to be diagnosed in the early stage of this disease and most patients are diagnosed in advanced stages, resulting in poor 5-year survival rates [3] . Therefore, finding the new diagnostic or prognostic markers and therapeutic targets to improve the identification of the pathogenic mechanisms involved in GC is necessary. microRNAs (miRNAs) are small, non-coding RNAs containing ~19-25 nucleotides [4] . miRNAs play critical roles in the post-transcriptional regulation of gene expression. Usually, the mature miRNAs lead to the translational repression or degradation of the target mRNAs through perfect or imperfect binding to the 3'-untranslated region (3' -UTR) of the target mRNAs [5] . A number of miRNAs have been demonstrated to participate in the tumourigenesis and progression of multiple tumors including GC via regulating several target genes [6] [7] [8] [9] . Most miRNAs play critical roles in regulating cell proliferation, migration, invasion, differentiation.
Forkhead BoxO1 (FOXO1) belongs to the forkhead box O (FOXO) subfamily of transcription factors which are characterized by a conserved forkhead DNA binding domain [10] . FOXO1 is known as a tumor suppressor and involved in a variety of biological progress, such as cell cycle, proliferation, differentiation, metastasis and apoptosis [11] [12] [13] [14] [15] . Several studies have demonstrated that FOXO1 is down-regulated in various types of cancer, including GC [12, [16] [17] [18] [19] . It has been reported that several miRNAs appear to be involved in the regulation of FOXO1, such as miR-135a, miR-582-5p, miR-182, miR-370, miR-96 [11, [19] [20] [21] [22] . However, the regulation of FOXO1 by miRNAs remains still unclear in gastric carcinogenesis.
In this study, we determined the expression level of miR-215 and FOXO1 in gastric cancer tissues and the corresponding noncancerous normal gastric mucosa tissues. We found that miR-215 was frequently up-regulated and FOXO1 was downregulated in GC cancer tissues. And then we detected the effect of miR-215 on cell migration and invasion of gastric cancer cells. We reported that overexpression of miR-215 in GC cells decreased FOXO1 protein levels, whereas depletion of miR-215 increased FOXO1 protein levels. Luciferase reporter assay showed that FOXO1 was the target of miR-215. Therefore, these results indicated that over-expressed miR-215 increased GC cell migration and invasion through directly targeting FOXO1. measured using the BCA reagent kit (Merck). The proteins were seperated by SDS-PAGE and were transferred to PVDF membrane. Then, the samples were incubated with primary antibody against FOXO1 (Santa Cruz) at 4 °C overnight and secondary antibody at room temperature for 1h, and protein was developed using the chemiluminescence method (ECL, Millipore). β-actin (Sigma-Aldrich) served as a loading control.
Transwell assay. Cell invasion and migration assays were performed using transwell chambers (pore size of 8 μM; Costar, Corning, NY) with or without 2 mg/mL Matrigel (Clontech, Mountain View, CA). Gastric cancer cells with different transfection treatments were harvested and resuspended in serum-free RPMI-1640 medium, and 1 ×10 5 cells were seeded into the upper 24-well chambers. RPMI-1640 medium containing 20% FBS was added to the lower chambers as a chemoattractant. After 24 h, the cells on the upper surface of the membrane were removed, and the cells on the lower surface were fixed with 100% methanol, stained with 0.05% crystal violet and photographed under a microscope. The number of migration cells was counted from three independent experiments.
Luciferase assay. Gastric cancer cells with different transfection treatments were collected 48 h after transfection and luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA). Renilla luciferase was used for normalization. The transfection experiments were performed in triplicate.
Statistical analysis. Statistical analyses were performed using the Statistical Package for the Social Sciences, version 17.0 (SPSS Inc., Chicago, IL, USA). The differences between the groups were analyzed using Student's t-test or χ 2 test. P < 0.05 was considered to be statistically significant.
Results

miR-215 is frequently up-regulated in GC.
To examine the expression level of miR-215 in gastric cancer, 50 pairs of gastric cancers and the corresponding non-cancerous tissues were quantified by real-time PCR. We found that the expression level of miR-215 was significantly up-regulated in 39/50(78%) of the clinical GC specimens ( Figure 1A) and the average expression level of miR-215 in tumor tissues was significantly higher than that in surrounding non-cancerous tissues (P < 0.0001; Figure 1B ). Clinicopathological analysis showed that miR-215 expression level was correlated with the progression of tumor invasion and TNM stage (Table 1 ). In addition, the miR-215 expression in the 5 GC cell lines (AGS, BGC-823, SGC-7901, HGC-27, MGC-803) was also markedly up-regulated, compared with normal gastric epithelial GES-1 cells ( Figure 1C ).
Additionally, we used real-time PCR to detect the expression level of FOXO1 in 50 pairs of gastric cancers and the corresponding non-cancerous tissues, found that FOXO1 was down-regulated in GC ( Figure 1D ). Statistical analysis showed that miR-215 expression was negatively associated with FOXO1 in the GC samples ( Figure 1E ). miR-215 promotes migration and invasion of GC cell. To investigate the function of miR-215 in gastric cancer cells, we transiently transfected the miR-215 mimics into GES-1 cell or inhibitor into the AGS cells. The transfection efficiency was verified by qRT-PCR (Figure 2A, 2B) . The transwell assays were used to detect the effect of the miR-215 mimics or inhibitor on cell migration and invasion. The results showed that miR-215 mimics promoted cell migration and invasion in GES-1 cells (Figure 2C, 2D) , whereas its inhibitor reduced cell migration and invasion ( Figure 2E, 2F ) in AGS cell, respectively. miR-215 directly targets FOXO1 3'-UTR and decreases FOXO1 expression. It has been well documented that miRNAs play an important roles in the regulation of gene expression mainly through binding to the 3'-UTR of target mRNA. We used different databases such as TargetScan, Mirnada and miRBase to predict the targets of miR-215 and found FOXO1 might be targeted by miR-215. Bioinformatics analysis revealed that there was one putative miR-215 binding site in the nucleotide sequence from 1715 to 1721 of FOXO1 3'-UTR ( Figure 3A) . Therefore, we transfected the miR-215 mimics or inhibitor in GC cells and used qRT-PCR and western blotting to determine the effect of miR-215 on the expression of FOXO1. The results showed that ectopic expression of miR-215 significantly decreased the expression of FOXO1 at protein and mRNA levels in AGS cell lines (Figure 3B, 3C) . Moreover, the inhibition of endogenous miR-215 by the miR-215 inhibitor significantly increased the protein and mRNA levels of FOXO1 in AGS cells ( Figure 3B, 3C) .
To determine whether FOXO1 is directly targeted by miR-215 in GC cells, we constructed luciferase reporter vector containing wild-type (WT) or mutant (Mut) seed regions of FOXO1. AGS cell was cotransfected with WT or Mut 3'-UTR luciferase reporters and miR-215 mimics. The luciferase activity was determined at 48 h post transfection. As shown in Figure 3D , ectopic expression of miR-215 decreased luciferase activity in cells transfected with wild-type FOXO1 3'-UTR and had no effect on luciferase activity in cells expressing with mutant FOXO1 3'-UTR reporter in AGS cell lines. These results suggested that FOXO1 was a direct target of miR-215 in GC cells.
Depletion of FOXO1 could reverse partial function of miR-215.
A number of evidences demonstrated that FOXO1 plays critical roles in the migration and invasion. Our data suggested that inhibition of miR-215 decreased GC cell migration and invasion. Next, we used FOXO1-specific siRNA to knockdown FOXO1 expression in AGS cells. The transfection efficiency of FOXO1 siRNA in GC cell was shown in Figure 4A , 4B. The transwell assay results showed that knockdown of FOXO1 increased the migration and invasion in AGS cells ( Figure 4C, 4D) . FOXO1 siRNA deprived miR-215 inhibitor-mediated inhibition of cell migration and invasion, suggesting that FOXO1 is involved in the miR-215-mediated biological role in gastric cancer cells ( Figure 4E, 4F) . Therefore, depletion of FOXO1 could reverse partial function of miR-215.
Discussion
GC remains one of the most frequently occurring malignancies worldwide and the prognosis of GC is very poor. Thus, further understanding the molecular mechanisms of GC is necessary. microRNAs (miRNAs) are important epigenetic regulators participating in the development and progression of various cancers types, including GC [23] [24] [25] . miRNAs act as oncogenes or tumor suppressors in tumors [24, [26] [27] [28] [29] . It has been reported that miR-215 plays important roles in a variety of tumor cancer. Previous studies showed that miR-215 was down-regulated in several cancers, such as, colon cancer [30] , breast cancer [31] , and lung cancer [32] . However, in this current study, we found that miR-215 is frequently up-regulated in GC and the average expression level of miR-215 in tumor tissues was significantly higher than that in surrounding non-cancerous tissues. This is consistent with previous studies [33, 34] . Moreover, miR-215 expression level was correlated with the progression of tumor invasion and TNM stage. Since miR-215 is frequently up-regulated in gastric cancer, we tried to explore the biological functions of miR-215 in GC. In this study, we confi rmed that miR-215 could promote the migration and invasion in GC cells. miR-215 mimics facilitated cell migration and invasion, whereas, miR-215 inhibitor reduced cell migration and invasion. Furthermore, we fi rst identifi ed FOXO1 as a novel direct target of miR-215 in GC cells using luciferase assay.
Forkhead box protein O1 (FOXO1), is a member of the FOXO family of transcription factors, functions as a tumor suppressor and involves in a variety of biological processes [35, 36] . Th ere are reports showing that FOXO1 was downregulated in some human cancers, including GC [12] . Several miRNAs were involved in the regulation of FOXO1. For example, Xu et al. found that FOXO1 is a direct target of miR-135b and down-regulation of miR-135b could inhibit growth of cervical cancer cells and decrease proliferation and invasion of osteosarcoma cells via targeting FOXO1 [37, 38] . Besides, Mao et al [11] and Guo et al [22] have demonstrated that miR-135a and miR-96 directly target FOXO1 and regulate FOXO1 protein expression in bladder cancer. Down-regulation of miR-135a or miR-96 leads to the up-regulation of FOXO1 protein. Th e downregulation of FOXO1 in prostate cancer cells and gastric cancer cells inhibit the migration and invasion [12, 39] . In this study, we found that the expression level of FOXO1 in GC tumor was signifi cantly lower than that in surrounding non-cancerous tissues. Statistical analysis showed that miR-215 expression was negatively associated with FOXO1 in the GC samples. Furthermore, we confi rmed the biologi- cal role of FOXO1 in gastric cancer and found that deletion of FOXO1 could inhibit the migration and invasion of GC cells. Th is is consistent with previous study that demonstrated FOXO1 shRNA signifi cantly increased migration and invasion compared with their respective controls [12] . Additionally, we found that depletion of FOXO1 could reverse partial function of miR-215 (Figure4).
In conclusion, our results suggest that miR-215 is frequently up-regulated and negatively associated with FOXO1 in gastric cancer. Moreover, the over-expression of miR-215 promotes the migration and invasion of GC cells by directly targeting FOXO1. Th us, these fi ndings indicate that miR-215 may be a potential diagnostic marker and a novel therapeutic target of gastric cancer. 
